Invesco Ltd. Vera Therapeutics, Inc. Transaction History
Invesco Ltd.
- $516 Billion
- Q4 2024
A detailed history of Invesco Ltd. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 21,954 shares of VERA stock, worth $627,445. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,954
Previous 20,510
7.04%
Holding current value
$627,445
Previous $906,000
2.43%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$160 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$125 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$95.4 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$84.6 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$84.3 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $773M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...